Skip to main content
SpringerLink
Log in

Stratification of Gastric Cancer Risk by H. pylori Infection

  • Chapter
  • First Online:
Book cover Helicobacter pylori

Abstract

Infection by Helicobacter pylori (H. pylori) has been clearly shown to be strongly associated with the development of gastric cancer and is even considered a necessary condition for its development. In addition, it has been shown that among individuals with H. pylori infection, those who have advanced atrophy of the gastric mucosa are at high risk for gastric cancer. It is possible to evaluate the state of H. pylori infection by a serum antibody test for H. pylori and to evaluate the degree of gastric mucosal atrophy by the pepsinogen (PG) method. Furthermore, it is possible to stratify the risk for gastric cancer by using the ABC classification, which combines serum H. pylori antibody testing and the PG method. In this classification, a group of individuals who are H. pylori antibody (−) and PG method (−) (group A) is considered to be at low risk; a group with H. pylori antibody (+) and PG method (−) (group B) is considered to be at average risk; and groups with H. pylori antibody (+) and PG method (+) (group C) or H. pylori antibody (−) and PG method (+) (group D) are considered to be at high risk. The ABC classification is a simple, objective blood test, which is being widely used because it has the major advantage of providing consistent results regardless of the evaluating clinicians. The use of appropriate imaging studies based on the ABC stratification of gastric cancer risk would be an effective strategy toward elimination of gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active gastritis. Lancet. 1983;321:1273–5.

    Article  Google Scholar 

  2. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer. BMJ. 1991;302:1302–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.

    Article  CAS  PubMed  Google Scholar 

  4. Nomura A, Stemmerman GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132–6.

    Article  CAS  PubMed  Google Scholar 

  5. WHO. Schistosomes, liver flukes and Helicobacter pylori: IARC working group on the evaluation of carcinogenic risks to humans, IARC monographs on the evaluation of carcinogenetic risks to humans, IARC scientific publication no. 61, vol. 61. Lyon: IARC; 1994. p. 218–20.

    Google Scholar 

  6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.

    Article  CAS  PubMed  Google Scholar 

  7. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2001;16:415–9. doi:10.1111/j.1523-5378.2011.06893.x.

    Article  Google Scholar 

  8. Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59–65. doi:10.1159/000339176. Epub 2012 Jun 20.

    Article  PubMed  Google Scholar 

  9. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 1998;115:642–8.

    Article  CAS  PubMed  Google Scholar 

  10. Kato S, Tsukamoto T, Mizoshita T, Tanaka H, Kumagai T, Ota H, et al. High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer. 2006;119:1558–66.

    Article  CAS  PubMed  Google Scholar 

  11. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process; First American cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.

    CAS  PubMed  Google Scholar 

  12. Masuyama H, Yoshitake N, Sasai T, Nakamura T, Masuyama A, Zuiki T, et al. Relationship between the degree of the endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91:30–6.

    Article  PubMed  Google Scholar 

  13. Inoue K, Fujisawa T, Chinuki D, Kushiyama Y. Characteristics of gastric mucosa in gastric cancer improvement – examination from a clinical survey by endoscopy. Stomach Intestine. 2009;44:1367–73 (in Japanese with English abstract).

    Google Scholar 

  14. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1:87–96.

    Article  Google Scholar 

  15. Kamada T, Hata J, Tanaka A, Kusunoki H, Miyamoto M, Inoue K, et al. Nodular gastritis and gastric cancer. Dig Endosc. 2006;18:79–83. doi:10.1111/j.0915-5635.2006.00588.x.

    Article  Google Scholar 

  16. Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K, Miyazaki Y, Yasunaga Y, et al. Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol. 2003;18:1384–91.

    Article  PubMed  Google Scholar 

  17. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori infection on subsequent development of cancer after endoscopic resection of gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639–42.

    CAS  PubMed  Google Scholar 

  18. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early cancer: an open-label, randomized controlled trial. Lancet. 2008;372:392–7. doi:10.1016/S0140-6736(08)61159-9.

    Article  PubMed  Google Scholar 

  19. Yohn SB, Park JM, Lim CH, Cho YK, Choi MG. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter. 2014;19:243–8. doi:10.1111/hel.12146.

    Article  Google Scholar 

  20. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;20:348:g3174. 10.1136/bmj.g3174.

    Google Scholar 

  21. Samloff IM. Pepsinogens I, and II; purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology. 1982;82:26–33.

    CAS  PubMed  Google Scholar 

  22. Samloff IM, Varis K, Ihamaki KT, Siurala M, Rotter JI. Relationship among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–9.

    CAS  PubMed  Google Scholar 

  23. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroentereol Jpn. 1987;22:133–41.

    CAS  Google Scholar 

  24. Miki K, Ichinose M, Ishikawa K, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res. 1993;84:1086–90.

    Article  CAS  PubMed  Google Scholar 

  25. Inoue K. Evaluation of serum pepsinogens and anti-H.pylori antibodies for screening of gastric cancer. Clin Gastroenterol. 2002;17:1591–8 (in Japanese with English abstract).

    Google Scholar 

  26. Inoue K, Fujisawa T, Haruma H. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers. 2010;25:207–12.

    PubMed  Google Scholar 

  27. Inoue K, Fujisawa T, Nishi T, et al. Utilities and problems of the ABC classification – including examination of the reference value of pepsinogens. Helicobacter Res. 2011;15:422–7 (in Japanese).

    Google Scholar 

  28. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109:138–43.

    Article  CAS  PubMed  Google Scholar 

  29. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74–94. doi:10.1055/s-0031-1291491. Epub 2011 Dec 23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–6.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ohshima A, Hirata N, Ubukata T, Fujimoto I. Evaluation of a mass screening program for stomach with a case-control study design. Int J Cancer. 1986;38:829–33.

    Article  Google Scholar 

  33. Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takao A. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan; a population-based case-control study. Int J Cancer. 1995;60:45–8.

    Article  CAS  PubMed  Google Scholar 

  34. Abe Y, Mitsushima T, Nagatani Y, Ikuma H, Minamihara Y. Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study. A study of efficient screening programma for stomach cancer. J Gastroenterol. 1995;92:836–45 (in Japanese).

    CAS  Google Scholar 

Download references

Acknowledgements and Disclosures

The author states that there is no involvement of funding sources.

The author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of General Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan

    Kazuhiko Inoue

Authors
  1. Kazuhiko Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhiko Inoue .

Editor information

Editors and Affiliations

  1. Medical Education Center, Keio University School of Medicine, Tokyo, Japan

    Hidekazu Suzuki

  2. The Royal Perth Hospital, The University of Western Australia and, Western Australia, West Australia, Australia

    Robin Warren

  3. The Royal Perth Hospital, The University of Western Australia and, Western Australia, Australia

    Barry Marshall

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Inoue, K. (2016). Stratification of Gastric Cancer Risk by H. pylori Infection. In: Suzuki, H., Warren, R., Marshall, B. (eds) Helicobacter pylori. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55705-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55705-0_11

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55704-3

  • Online ISBN: 978-4-431-55705-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation